Sensory Neurons, Motor Neurons, and More: Field-Tested Applications for hiPSC-Derived Cells

Anatomic Incorporated is the world-leader in efficient production of neurons from human pluripotent stem cells. We provide cryopreserved cells and 7 day differentiation kits for human disease modeling, toxicity assessment, and basic discovery research. This session will highlight a number collaborators and users of our hiPSC derived sensory neurons and differentiation kits for different drug discovery assays and screening applications. We will also discuss a number of new cell types we are launching including motor neurons, Schwann cells, melanocytes, and more along with their applications for next-gen in vitro human models.

8:30 AM - 8:40 AM: Vincent Truong - Anatomic Incorporated - "Novel Differentiation Protocols and Assay Development Strategies at Anatomic"
8:40 AM - 8:55 AM: Ronald Knox - Nanion Technologies - "Characterization of mechanosensory and pain ion channel receptors on automated patch clamp"
8:55 AM - 9:10 AM: Raymond Price - Neuroservices Alliance USA - "Patch clamp profiling the functional properties of human iPSC-derived nociceptors"
9:10 AM - 9:25 AM: Chelsey Derderian-LeBlang - Harvard Medical School and Dana Farber Cancer Institute (15 min) - “Elucidating mechanisms underlying axonal degeneration in CIPN patient derived induced human sensory neurons”
9:25 AM - 9:40 AM: Larissa Butler - Charles River Laboratories - "Development of a Human Sensory Neuron Multi-Electrode Array (MEA) Assay"
9:40 AM - 9:55 AM: Patrick Walsh - Anatomic Incorporated - “Completing the Circuit: New Cell Types in the Anatomic Ecosystem for Modeling Advanced Biology”